Related Experiment Videos
Death ligands and autoimmune demyelination.
Orhan Aktas1, Timour Prozorovski, Frauke Zipp
1Institute of Neuroimmunology, Clinical and Experimental Neuroimmunology, Charité--Universitätsmedizin Berlin, Germany.
Summary
Apoptosis, a cell suicide process, plays a dual role in multiple sclerosis (MS). While impaired apoptosis can increase harmful T cells, its local tissue damage contributes to MS symptoms.
Area of Science:
- Immunology
- Cell Biology
- Neuroscience
Background:
- Apoptosis is a crucial cellular process for tissue homeostasis and development.
- Dysregulated apoptosis is implicated in autoimmune diseases like multiple sclerosis (MS).
- Death ligands, particularly from the tumor necrosis factor (TNF) family, mediate apoptosis.
Purpose of the Study:
- To review the role of apoptosis-mediating and immune regulatory death ligands in the pathogenesis of MS.
- To explore the implications of these ligands for MS therapeutic strategies.
Main Methods:
- Literature review of current knowledge on death ligands and MS.
- Analysis of the dual role of apoptosis in MS and its animal model, experimental autoimmune encephalomyelitis.
Main Results:
- Apoptosis has a complex role in MS: impaired apoptosis can lead to persistent autoreactive T cells, while excessive apoptosis contributes to tissue damage and clinical symptoms.
- Several TNF family death ligands (e.g., TNF, CD95L, TRAIL) are involved in MS pathogenesis.
Conclusions:
- Understanding the specific roles of different death ligands in MS is crucial for developing targeted therapies.
- Modulating apoptosis pathways presents a potential therapeutic avenue for managing MS.